Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26207-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- HDAC7 antibody
- Antibody type
- Polyclonal
- Description
- HDAC7 antibody (Cat. #26207-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, rat and has been validated for the following applications: IP,ELISA.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references DNMT3a promotes LUAD cell proliferation and metastasis by activating the HDAC7 signalling pathway.
ARID1A deficiency promotes malignant proliferation of hepatocellular carcinoma by activating HDAC7/ENO1 signaling pathway.
Interplay between acetylation and ubiquitination controls PSAT1 protein stability in lung adenocarcinoma.
AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway.
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.
Discovery of a novel HDACi structure that inhibits the proliferation of ovarian cancer cells in vivo and in vitro.
FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7.
Jiang M, Zhou X, Feng Y, Ding P, Li J, Lu D, Qin J, Bai Y, Wang A, Xia C, Wang J, Yan X, Ma Z, Zhang R
International journal of biological sciences 2025;21(4):1585-1602
International journal of biological sciences 2025;21(4):1585-1602
ARID1A deficiency promotes malignant proliferation of hepatocellular carcinoma by activating HDAC7/ENO1 signaling pathway.
Zhang S, Wu G, Shi L, Ding P, Liu G, Chang W, Dai Y, Han X, Ma X
Hepatology communications 2025 Jul 1;9(7)
Hepatology communications 2025 Jul 1;9(7)
Interplay between acetylation and ubiquitination controls PSAT1 protein stability in lung adenocarcinoma.
Liu Y, Xun W, Zhao T, Huang M, Sun L, Wen G, Kang X, Wang J, Han T
Communications biology 2024 Oct 21;7(1):1365
Communications biology 2024 Oct 21;7(1):1365
AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway.
Deng L, Bao W, Zhang B, Zhang S, Chen Z, Zhu X, He B, Wu L, Chen X, Deng T, Chen B, Yu Z, Wang Y, Chen G
Cell death & disease 2023 Sep 5;14(9):590
Cell death & disease 2023 Sep 5;14(9):590
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.
Guo K, Ma Z, Zhang Y, Han L, Shao C, Feng Y, Gao F, Di S, Zhang Z, Zhang J, Tabbò F, Ekman S, Suda K, Cappuzzo F, Han J, Li X, Yan X
Journal of experimental & clinical cancer research : CR 2022 Mar 11;41(1):91
Journal of experimental & clinical cancer research : CR 2022 Mar 11;41(1):91
Discovery of a novel HDACi structure that inhibits the proliferation of ovarian cancer cells in vivo and in vitro.
Bai M, Cui M, Li M, Yao X, Wu Y, Zheng L, Sun L, Song Q, Wang S, Liu L, Yu C, Huang Y
International journal of biological sciences 2021;17(13):3493-3507
International journal of biological sciences 2021;17(13):3493-3507
FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7.
Nie X, Jia W, Li X, Pan X, Yin R, Liu N, Su Z
Cell biology international 2021 Oct;45(10):2150-2158
Cell biology international 2021 Oct;45(10):2150-2158
No comments: Submit comment
No validations: Submit validation data